USIO Form 4: Elizabeth Miller Receives 21,000 Time‑Vesting RSUs
Rhea-AI Filing Summary
Elizabeth Michelle Miller, a director of Usio, Inc. (USIO), was granted restricted stock units (RSUs) totaling 21,000 shares on 08/21/2025. The RSUs vest in three equal tranches of 7,000 shares on 08/21/2026, 08/21/2027 and 08/21/2028 and convert into common stock. Each grant shows an exercise/conversion price of $0.0000 and an expiration date of 08/21/2035. Following these reported transactions, Ms. Miller beneficially owns 37,000 shares of USIO common stock. The Form 4 was signed by Ms. Miller on 08/22/2025.
Positive
- Director granted 21,000 RSUs on 08/21/2025, providing retention incentives
- Clear vesting schedule (08/21/2026, 08/21/2027, 08/21/2028) improves transparency
- Form 4 timely signed (08/22/2025) and discloses conversion price and expiration
Negative
- None.
Insights
TL;DR: Director received time‑based RSUs totaling 21,000 shares; this is routine compensation with limited immediate market impact.
The grant comprises three equal tranches vesting annually from 2026 through 2028, indicating standard retention incentive for a director rather than a performance‑conditioned award. The conversion price is $0.0000, consistent with restricted stock unit treatment. The incremental increase to 37,000 shares outstanding to the director is disclosed; absent larger context on share count or dilution, this is unlikely to be material to valuation. No sales or dispositions were reported.
TL;DR: Grant structure reflects typical director compensation and retention practices; disclosure appears complete for Form 4 purposes.
The awards are standard time‑vesting RSUs with clear vesting and expiration dates disclosed on the form. The filing indicates the reporting person is a director and the transactions were reported promptly. There is no indication of related‑party transactions, unusual acceleration, or rule 10b5‑1 plan checkbox marked. From a governance standpoint, the disclosure fulfills Section 16 requirements and signals alignment incentives without immediate corporate control implications.